The application of a three-dimensional visualized seed planning and navigation system in ¹²⁵I seed implantation for pancreatic cancer

References

• JemalABrayFCenterMMGlobal cancer statisticsCA Cancer J Clin2011612699021296855
   PubMed Web of Science ®Google Scholar
• WinterJMBrennanMFTangLHSurvival after resection of pancreatic adenocarcinoma: results from a single institution over three decadesAnn Surg Oncol201219116917521761104
   PubMed Web of Science ®Google Scholar
• SpadiRBrusaFPonzettiACurrent therapeutic strategies for advanced pancreatic cancer: a review for cliniciansWorld J Clin Oncol201671274326862489
   PubMedGoogle Scholar
• PuleoFMarechalRDemetterPNew challenges in perioperative management of pancreatic cancerWorld J Gastroenterol20152182281229325741134
   PubMed Web of Science ®Google Scholar
• JemalASiegelRXuJCancer statistics, 2010CA Cancer J Clin201060527730020610543
   PubMed Web of Science ®Google Scholar
• CameronJLRiallTSColemanJOne thousand consecutive pancreaticoduodenectomiesAnn Surg20062441101516794383
   PubMed Web of Science ®Google Scholar
• LongJZhangYYuXOvercoming drug resistance in pancreatic cancerExpert Opin Ther Targets201115781782821391891
   PubMed Web of Science ®Google Scholar
• ZhongminWYuLFenjuLClinical efficacy of CT-guided iodine-125 seed implantation therapy in patients with advanced pancreatic cancerEur Radiol20102071786179120069424
   PubMed Web of Science ®Google Scholar
• XiangZLiGLiuZ125I brachytherapy in locally advanced nonsmall cell lung cancer after progression of concurrent radiochemotherapyMedicine20159449e224926656370
   PubMed Web of Science ®Google Scholar
• QinQHHuangBSTanQXRadiobiological effect induced by different activities of (125)I seed brachytherapy in a hepatocellular carcinoma modelInt J Clin Exp Med20147125260526725664029
   PubMed Web of Science ®Google Scholar
• BadakhshiHGrafRBudachVPermanent interstitial low-dose-rate brachytherapy for patients with low risk prostate cancer: an interim analysis of 312 casesStrahlenther Onkol2015191430330925339309
   PubMed Web of Science ®Google Scholar
• WangGZhangFYangBFeasibility and clinical value of CT-guided (125)I brachytherapy for bilateral lung recurrences from colorectal carcinomaRadiology2016278389790526406550
   PubMed Web of Science ®Google Scholar
• JinZDuYLiZEndoscopic ultrasonography-guided interstitial implantation of iodine 125-seeds combined with chemotherapy in the treatment of unresectable pancreatic carcinoma: a prospective pilot studyEndoscopy200840431432018283622
   PubMed Web of Science ®Google Scholar
• GrimmPDBlaskoJCSylvesterJE10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapyInt J Radiat Oncol Biol Phys2001511314011516848
   PubMed Web of Science ®Google Scholar
• WangHWangJJiangYThe investigation of 125I seed implantation as a salvage modality for unresectable pancreatic carcinomaJ Exp Clin Cancer Res20133210624370348
   PubMed Web of Science ®Google Scholar
• ShipleyWUNardiGLCohenAMIodine-125 implant and external beam irradiation in patients with localized pancreatic carcinoma: a comparative study to surgical resectionCancer19804547097146244074
   PubMed Web of Science ®Google Scholar
• WangJJiangYLiJIntraoperative ultrasound-guided iodine-125 seed implantation for unresectable pancreatic carcinomaJ Exp Clin Cancer Res2009288819545454
   PubMed Web of Science ®Google Scholar
• RaimondiSMaisonneuvePLowenfelsABEpidemiology of pancreatic cancer: an overviewNat Rev Gastroenterol Hepatol200961269970819806144
   PubMed Web of Science ®Google Scholar
• GuttRLiauwSLWeichselbaumRRThe role of radiotherapy in locally advanced pancreatic carcinomaNat Rev Gastroenterol Hepatol20107843744720628346
   PubMed Web of Science ®Google Scholar
• AndreTBalossoJLouvetCCombined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility studyInt J Radiat Oncol Biol Phys200046490391110705012
   PubMed Web of Science ®Google Scholar
• MahadevanAJainSGoldsteinMStereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancerInt J Radiat Oncol Biol Phys201078373574220171803
   PubMed Web of Science ®Google Scholar
• SchellenbergDKimJChristman-SkiellerCSingle-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancerInt J Radiat Oncol Biol Phys201181118118821549517
   PubMed Web of Science ®Google Scholar
• PolistinaFCostantinGCasamassimaFUnresectable locally advanced pancreatic cancer: a multimodal treatment using neoadjuvant chemoradiotherapy (gemcitabine plus stereotactic radiosurgery) and subsequent surgical explorationAnn Surg Oncol20101782092210120224860
   PubMed Web of Science ®Google Scholar
• NagaiSFujiiTKoderaYPrognostic implications of intraoperative radiotherapy for unresectable pancreatic cancerPancreatology2011111687521525774
   PubMed Web of Science ®Google Scholar
• OgawaKKarasawaKItoYIntraoperative radiotherapy for unresectable pancreatic cancer: a multi-institutional retrospective analysis of 144 patientsInt J Radiat Oncol Biol Phys201180111111820598450
   PubMed Web of Science ®Google Scholar
• ZhangXHuangHJFengDIs concomitant radiotherapy necessary with gemcitabine-based chemotherapy in pancreatic cancer?World J Gastroenterol20142046176481765525516680
   PubMed Web of Science ®Google Scholar
• ChenYSunXJJiangTHCombined radiochemotherapy in patients with locally advanced pancreatic cancer: a meta-analysisWorld J Gastroenterol201319427461747124259979
   PubMed Web of Science ®Google Scholar
• KessenbrockKPlaksVWerbZMatrix metalloproteinases: regulators of the tumor microenvironmentCell20101411526720371345
   PubMed Web of Science ®Google Scholar
• KindlerHLNiedzwieckiDHollisDGemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303)J Clin Oncol201028223617362220606091
   PubMed Web of Science ®Google Scholar
• OverallCMKleifeldOTumour microenvironment – opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapyNat Rev Cancer20066322723916498445
   PubMed Web of Science ®Google Scholar
• Paez-RibesMAllenEHudockJAntiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasisCancer Cell200915322023119249680
   PubMed Web of Science ®Google Scholar
• EisenhauerEATherassePBogaertsJNew response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)Eur J Cancer200945222824719097774
   PubMed Web of Science ®Google Scholar